ZEB2 Antibody (923328) [Alexa Fluor® 350] Summary
E. coli-derived recombinant human ZEB2/SIP1
Asn363-Lys537
Accession # O60315
Asn363-Lys537
Accession # O60315
Detects human ZEB2/SIP1 in direct ELISAs.
N/A
IgG2b
Monoclonal
Mouse
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Intracellular Staining by Flow Cytometry 0.25-1 ug/10^6 cells
Packaging, Storage & Formulations
- 12 months from date of receipt, 2 to 8 °C as supplied.
Protect from light. Do not freeze.
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for ZEB2 Antibody (923328) [Alexa Fluor® 350]
- HSPC082
- KIAA0569FLJ42816
- SIP1
- SIP1HSPC082
- Smad-interacting protein 1
- SMADIP1
- SMADIP1ZFHX1BSIP-1
- ZEB2
- ZFHX1B
- ZFX1B
- zinc finger E-box binding homeobox 2
- zinc finger E-box-binding homeobox 2
- zinc finger homeobox 1b
- Zinc finger homeobox protein 1b
Background
SIP1 (Smad-interacting protein 1), also called ZEB2 (Zinc finger E-box-binding homeobox 2), is a nuclear transcription factor. SIP1 contains seven C2H2-type zinc finger domains within amino acids (aa) 211-334 and 999-1076, a Smad-MHZ binding domain (aa 437-487), an atypical homeobox domain (aa 644-703), and phosphorylation, sumoylation and acetylation sites. The 1214 aa SIP1 gives a calculated molecular weight of 136 kDa, but may actually appear closer to 200 kDa due to modifications. A 1190 aa isoform lacks aa 111-134. Within aa 363-537, human SIP1 shares 98% and 97% aa sequence identity with mouse and rat SIP1, respectively. SIP1 is highly expressed in postmitotic neocortical cells and influences cell fate decisions in embryonic brain development. Point mutations causing underexpression of SIP1 are associated with Mowat-Wilson syndrome (MWIS), also known as Hirschprung disease mental retardation syndrome.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets : PKA inhibitors